Marsh & McLennan Companies, Inc. — Q1 2024 Form 10-Q
Business context and period: Global professional services firm reporting for the three months ended March 31, 2024, compared with the prior-year quarter. Its segments are Risk and Insurance Services (Marsh and Guy Carpenter) and Consulting (Mercer and Oliver Wyman Group).
Financial performance
| Metric | Q1 2024 | Q1 2023 | Change |
|---|---|---|---|
| Revenue | $6.473 billion | $5.924 billion | +9%; underlying growth also 9% |
| Operating income | $1.925 billion | $1.726 billion | +12% |
| Operating margin | 29.7% | 29.1% | +0.6 percentage points |
| Net income attributable to MMC | $1.400 billion | $1.235 billion | +13% |
| Diluted EPS | $2.82 | $2.47 | +14% |
| Operating cash flow | $(781) million | $(819) million | Cash use narrowed by $38 million |
Operating expenses rose 8% to $4.548 billion, reflecting higher salaries, incentive compensation and headcount. Net income margin was approximately 21.6%, versus 20.8% a year earlier. Effective tax rate was 23.9%, down from 24.7%.
Segments
- Risk and Insurance Services: Revenue $4.273 billion, up 9% (underlying +9%); operating income $1.565 billion versus $1.395 billion; margin 36.6% versus 35.7%. Revenue benefited from new business, renewals, higher insurance and reinsurance pricing, and fiduciary interest income, which rose to $122 million from $91 million.
- Consulting: Revenue $2.214 billion, up 9% (underlying +9%); operating income $432 million versus $411 million; margin 19.5% versus 20.2%. Oliver Wyman revenue increased 15% reported and 13% underlying. Mercer underlying revenue grew 6%, with Health +10%, Wealth +5%, and Career +1%.
Liquidity, debt and capital
- Cash and cash equivalents available for corporate purposes were $1.452 billion at quarter-end, versus $3.358 billion at December 31, 2023. An additional $11.458 billion was held in a fiduciary capacity and is not available for corporate use.
- Short- and long-term debt totaled approximately $13.469 billion, compared with $13.463 billion at year-end. MMC had $50 million of commercial paper outstanding and no borrowings under its $3.5 billion revolving credit facility.
- In February, MMC issued $1 billion of senior notes: $500 million at 5.150% due 2034 and $500 million at 5.450% due 2054. It repaid $1 billion of 3.875% notes at maturity in March. Interest expense increased to $159 million from $136 million.
- Investing cash outflow was $368 million, including $301 million net cash used for acquisitions. Financing cash inflow was $135 million. The quarter-end decline in total corporate and fiduciary cash also reflects a $228 million adverse foreign-exchange effect.
- MMC repurchased 1.5 million shares for $300 million, paid $354 million in dividends, and declared a quarterly dividend of $0.71 per share payable in May. Approximately $2.9 billion remained authorized for repurchases.
Negative first-quarter operating cash flow primarily reflects working-capital timing, including accrued compensation payments; it was less negative than in Q1 2023. Current assets and liabilities include substantial matching fiduciary balances, so headline current liquidity ratios should be interpreted with care.
Material changes, outlook and risks
- MMC completed six acquisitions in the quarter for total consideration of $359 million. Acquired businesses contributed approximately $14 million of revenue and a $6 million operating loss in the period. The company also sold Mercer’s U.K. pension administration and U.S. health and benefits administration businesses for approximately $114 million and recorded a $21 million net gain; related exit costs were $18 million.
- Restructuring costs were $42 million, down from $53 million in Q1 2023; $30 million related to the program begun in 2022. Remaining costs are expected by year-end 2024.
- Prior-year expenses included $51 million of insurance and indemnity recoveries related to a legacy JLT errors-and-omissions matter, creating a comparison benefit not present in Q1 2024.
- Management cited continued client demand, new business and renewals, global economic growth, inflation, insurance pricing and higher fiduciary interest income. No quantified full-year earnings or revenue guidance is provided in the filing.
- Risks include geopolitical and macroeconomic disruption, cyberattacks, talent retention, competition and technology change, regulation, conflicts of interest, foreign-exchange and interest-rate exposure, and tax uncertainty. Pending claims and proceedings include Greensill-related litigation and a Brazilian competition investigation; MMC says it cannot reasonably estimate possible losses, and adverse outcomes could materially affect future results or cash flows.
- Foreign-currency translation reduced first-quarter equity by $218 million. Management estimates a 10% move in major currencies in the same direction against the U.S. dollar could change annual net operating income by about $85 million; the filing estimates current exchange rates would reduce full-year net operating income by about $25 million year over year.
Important facts for investors to verify
- Track whether 9% underlying revenue growth and segment demand persist, particularly Mercer’s Wealth and Health trends.
- Assess operating-margin movement: Consulting margin declined despite revenue growth; also account for the prior-year $51 million recovery and the 2024 divestiture gain and exit costs.
- Monitor cash conversion and working-capital seasonality, while excluding fiduciary funds from corporate liquidity assessment.
- Review the cost and maturity profile of new debt, refinancing needs, and the effect of higher interest expense.
- Follow acquisition integration and final purchase-price allocations, restructuring completion, tax developments, and the outcome of material legal matters.